nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA6—submandibular gland—pharynx cancer	0.328	0.329	CbGeAlD
Methazolamide—CA6—saliva—pharynx cancer	0.118	0.118	CbGeAlD
Methazolamide—CA6—ear—pharynx cancer	0.108	0.108	CbGeAlD
Methazolamide—CA6—mouth—pharynx cancer	0.0447	0.0447	CbGeAlD
Methazolamide—CA6—parotid gland—pharynx cancer	0.0311	0.0312	CbGeAlD
Methazolamide—CA6—saliva-secreting gland—pharynx cancer	0.0298	0.0298	CbGeAlD
Methazolamide—CA7—trachea—pharynx cancer	0.0237	0.0238	CbGeAlD
Methazolamide—CA6—head—pharynx cancer	0.0161	0.0162	CbGeAlD
Methazolamide—CA4—neck—pharynx cancer	0.0159	0.0159	CbGeAlD
Methazolamide—CA14—spinal cord—pharynx cancer	0.0156	0.0156	CbGeAlD
Methazolamide—CA12—trachea—pharynx cancer	0.0154	0.0154	CbGeAlD
Methazolamide—CA2—mouth—pharynx cancer	0.0154	0.0154	CbGeAlD
Methazolamide—CA2—neck—pharynx cancer	0.0132	0.0132	CbGeAlD
Methazolamide—CA4—parotid gland—pharynx cancer	0.0129	0.0129	CbGeAlD
Methazolamide—CA4—saliva-secreting gland—pharynx cancer	0.0124	0.0124	CbGeAlD
Methazolamide—CA4—brainstem—pharynx cancer	0.0121	0.0121	CbGeAlD
Methazolamide—CA12—head—pharynx cancer	0.0108	0.0108	CbGeAlD
Methazolamide—CA2—parotid gland—pharynx cancer	0.0107	0.0107	CbGeAlD
Methazolamide—CA1—lymphoid tissue—pharynx cancer	0.0106	0.0106	CbGeAlD
Methazolamide—CA2—saliva-secreting gland—pharynx cancer	0.0103	0.0103	CbGeAlD
Methazolamide—CA2—brainstem—pharynx cancer	0.0101	0.0101	CbGeAlD
Methazolamide—CA5B—head—pharynx cancer	0.00971	0.00972	CbGeAlD
Methazolamide—CA1—spinal cord—pharynx cancer	0.00964	0.00966	CbGeAlD
Methazolamide—CA4—trachea—pharynx cancer	0.00955	0.00956	CbGeAlD
Methazolamide—CA2—epithelium—pharynx cancer	0.00895	0.00896	CbGeAlD
Methazolamide—CA1—head—pharynx cancer	0.00857	0.00858	CbGeAlD
Methazolamide—CA2—trachea—pharynx cancer	0.00792	0.00792	CbGeAlD
Methazolamide—CA4—spinal cord—pharynx cancer	0.00754	0.00755	CbGeAlD
Methazolamide—CA2—lymphoid tissue—pharynx cancer	0.00689	0.0069	CbGeAlD
Methazolamide—CA5B—lymph node—pharynx cancer	0.0068	0.0068	CbGeAlD
Methazolamide—CA4—head—pharynx cancer	0.0067	0.00671	CbGeAlD
Methazolamide—CYP2D6—brainstem—pharynx cancer	0.00638	0.00639	CbGeAlD
Methazolamide—CA2—spinal cord—pharynx cancer	0.00625	0.00626	CbGeAlD
Methazolamide—CA1—lymph node—pharynx cancer	0.006	0.00601	CbGeAlD
Methazolamide—CA2—head—pharynx cancer	0.00556	0.00556	CbGeAlD
Methazolamide—CYP2E1—lymphoid tissue—pharynx cancer	0.00553	0.00553	CbGeAlD
Methazolamide—CYP2E1—spinal cord—pharynx cancer	0.00501	0.00502	CbGeAlD
Methazolamide—CA4—lymph node—pharynx cancer	0.00469	0.0047	CbGeAlD
Methazolamide—CYP2E1—head—pharynx cancer	0.00445	0.00446	CbGeAlD
Methazolamide—CA2—lymph node—pharynx cancer	0.00389	0.00389	CbGeAlD
Methazolamide—CYP2D6—head—pharynx cancer	0.00353	0.00353	CbGeAlD
Methazolamide—CYP2E1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	9.25e-05	0.082	CbGpPWpGaD
Methazolamide—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	8.11e-05	0.0719	CbGpPWpGaD
Methazolamide—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	6.56e-05	0.0582	CbGpPWpGaD
Methazolamide—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	5.76e-05	0.051	CbGpPWpGaD
Methazolamide—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	4.29e-05	0.038	CbGpPWpGaD
Methazolamide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	3.76e-05	0.0334	CbGpPWpGaD
Methazolamide—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	2.6e-05	0.0231	CbGpPWpGaD
Methazolamide—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	2.28e-05	0.0202	CbGpPWpGaD
Methazolamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	2.01e-05	0.0178	CbGpPWpGaD
Methazolamide—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	1.85e-05	0.0164	CbGpPWpGaD
Methazolamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	1.83e-05	0.0162	CbGpPWpGaD
Methazolamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	1.76e-05	0.0156	CbGpPWpGaD
Methazolamide—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	1.62e-05	0.0144	CbGpPWpGaD
Methazolamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	1.61e-05	0.0142	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—CNDP2—pharynx cancer	1.53e-05	0.0136	CbGpPWpGaD
Methazolamide—CA1—C-MYB transcription factor network—CCND1—pharynx cancer	1.47e-05	0.013	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—ADH7—pharynx cancer	1.38e-05	0.0123	CbGpPWpGaD
Methazolamide—CA14—Metabolism—CNDP2—pharynx cancer	1.33e-05	0.0118	CbGpPWpGaD
Methazolamide—CA6—Metabolism—CNDP2—pharynx cancer	1.29e-05	0.0115	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—CNDP2—pharynx cancer	1.29e-05	0.0115	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—ADH1B—pharynx cancer	1.21e-05	0.0108	CbGpPWpGaD
Methazolamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	1.21e-05	0.0107	CbGpPWpGaD
Methazolamide—CA7—Metabolism—CNDP2—pharynx cancer	1.21e-05	0.0107	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—CNDP2—pharynx cancer	1.21e-05	0.0107	CbGpPWpGaD
Methazolamide—CA14—Metabolism—ADH7—pharynx cancer	1.2e-05	0.0106	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	1.18e-05	0.0105	CbGpPWpGaD
Methazolamide—CA6—Metabolism—ADH7—pharynx cancer	1.17e-05	0.0104	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—ADH7—pharynx cancer	1.17e-05	0.0104	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CNDP2—pharynx cancer	1.12e-05	0.00992	CbGpPWpGaD
Methazolamide—CA7—Metabolism—ADH7—pharynx cancer	1.09e-05	0.00968	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—ADH7—pharynx cancer	1.09e-05	0.00968	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	1.09e-05	0.00962	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	1.08e-05	0.00954	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—ADH7—pharynx cancer	1.07e-05	0.00946	CbGpPWpGaD
Methazolamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	1.06e-05	0.00939	CbGpPWpGaD
Methazolamide—CA14—Metabolism—ADH1B—pharynx cancer	1.05e-05	0.00933	CbGpPWpGaD
Methazolamide—CA6—Metabolism—ADH1B—pharynx cancer	1.03e-05	0.00909	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—ADH1B—pharynx cancer	1.03e-05	0.00909	CbGpPWpGaD
Methazolamide—CA12—Metabolism—ADH7—pharynx cancer	1.01e-05	0.00897	CbGpPWpGaD
Methazolamide—CA14—Metabolism—B4GALT5—pharynx cancer	1.01e-05	0.00892	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—ADH7—pharynx cancer	9.82e-06	0.0087	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—B4GALT5—pharynx cancer	9.81e-06	0.00869	CbGpPWpGaD
Methazolamide—CA6—Metabolism—B4GALT5—pharynx cancer	9.81e-06	0.00869	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—ADH7—pharynx cancer	9.73e-06	0.00863	CbGpPWpGaD
Methazolamide—CA7—Metabolism—ADH1B—pharynx cancer	9.58e-06	0.00849	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—ADH1B—pharynx cancer	9.58e-06	0.00849	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	9.36e-06	0.0083	CbGpPWpGaD
Methazolamide—CA7—Metabolism—B4GALT5—pharynx cancer	9.15e-06	0.00811	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—B4GALT5—pharynx cancer	9.15e-06	0.00811	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CNDP2—pharynx cancer	8.92e-06	0.00791	CbGpPWpGaD
Methazolamide—CA12—Metabolism—ADH1B—pharynx cancer	8.87e-06	0.00786	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	8.61e-06	0.00763	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CNDP2—pharynx cancer	8.56e-06	0.00758	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	8.54e-06	0.00756	CbGpPWpGaD
Methazolamide—CA12—Metabolism—B4GALT5—pharynx cancer	8.48e-06	0.00752	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CNDP2—pharynx cancer	8.2e-06	0.00727	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ADH7—pharynx cancer	8.07e-06	0.00715	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ADH7—pharynx cancer	7.74e-06	0.00686	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ADH7—pharynx cancer	7.42e-06	0.00657	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CNDP2—pharynx cancer	7.21e-06	0.00639	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	7.1e-06	0.00629	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ADH1B—pharynx cancer	7.08e-06	0.00627	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ADH1B—pharynx cancer	6.78e-06	0.00601	CbGpPWpGaD
Methazolamide—CA4—Metabolism—B4GALT5—pharynx cancer	6.76e-06	0.00599	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ADH7—pharynx cancer	6.52e-06	0.00578	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ADH1B—pharynx cancer	6.5e-06	0.00576	CbGpPWpGaD
Methazolamide—CA2—Metabolism—B4GALT5—pharynx cancer	6.48e-06	0.00575	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—ADH7—pharynx cancer	6.42e-06	0.00569	CbGpPWpGaD
Methazolamide—CA1—Metabolism—B4GALT5—pharynx cancer	6.22e-06	0.00551	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ADH1B—pharynx cancer	5.72e-06	0.00507	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	5.63e-06	0.00499	CbGpPWpGaD
Methazolamide—CA9—Metabolism—B4GALT5—pharynx cancer	5.47e-06	0.00484	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—TP53—pharynx cancer	3.4e-06	0.00301	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CNDP2—pharynx cancer	2.62e-06	0.00232	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ADH7—pharynx cancer	2.37e-06	0.0021	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ADH1B—pharynx cancer	2.08e-06	0.00184	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CNDP2—pharynx cancer	2.02e-06	0.00179	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—B4GALT5—pharynx cancer	1.98e-06	0.00176	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CNDP2—pharynx cancer	1.86e-06	0.00165	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CNDP2—pharynx cancer	1.84e-06	0.00163	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ADH7—pharynx cancer	1.83e-06	0.00162	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ADH7—pharynx cancer	1.68e-06	0.00149	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ADH7—pharynx cancer	1.66e-06	0.00148	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ADH1B—pharynx cancer	1.6e-06	0.00142	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—B4GALT5—pharynx cancer	1.53e-06	0.00136	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ADH1B—pharynx cancer	1.47e-06	0.0013	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ADH1B—pharynx cancer	1.46e-06	0.00129	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—B4GALT5—pharynx cancer	1.41e-06	0.00125	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—B4GALT5—pharynx cancer	1.4e-06	0.00124	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CNDP2—pharynx cancer	1.21e-06	0.00108	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADH7—pharynx cancer	1.1e-06	0.000973	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADH1B—pharynx cancer	9.63e-07	0.000853	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—B4GALT5—pharynx cancer	9.2e-07	0.000815	CbGpPWpGaD
